![]() | |
Company type | Public |
---|---|
Industry | Health technology |
Founded | 1941 |
Founder | Homer Stryker |
Headquarters | Kalamazoo, Michigan, U.S. Newbury, Berkshire, U.K. |
Key people | Kevin A. Lobo (Chairman and CEO) Timothy J. Scannell (President and COO) Ronda Stryker (Director) |
Products |
|
Revenue | ![]() |
![]() | |
![]() | |
Total assets | ![]() |
Total equity | ![]() |
Owner | John W. Brown (5.3%) Ronda Stryker (4.6%) Jon Stryker Pat Stryker |
Number of employees | 53,000 (2024) |
Website | stryker |
Footnotes /references [1] [2] |
Stryker Corporation is an American multinational medical technologies corporation based in Kalamazoo, Michigan. The company's products are used for medical surgery and neurotechnology (60% of 2024 revenues), which include surgical equipment, patient and caregiver safety technologies, endoscopy systems, and patient handling, emergency medical equipment, and intensive care disposable products, as well as neurosurgical, neurovascular and oral and maxillofacial surgery implant products; and orthopedic surgery (40% of 2024 revenues), which includes implants used in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries. [1] Stryker's products are sold in over 75 countries and are used by 150 million patients annually. [1] In 2024, 75% of the company's revenues came from the United States. [1]
The company is ranked 195th on the Fortune 500 [3] and 331st on the Forbes Global 2000. [4]
In 1941, The Orthopedic Frame Company was founded by Homer Stryker, an orthopedist from Kalamazoo, Michigan. [1] Stryker developed the Turning Frame, a mobile hospital bed that allowed for repositioning of injured patients while providing necessary body immobility; the cast cutter, a cast cutting apparatus that removed cast material without damaging underlying tissues; and the walking heel, among others. In 1964, the company name was changed to Stryker Corporation. [5] [6]
In 1977, John W. Brown joined as president and CEO and became chairman in 1981. He transitioned to chairman in 2003. [7] In 2009, Brown retired as chairman after 32 years with the company. Under his leadership, revenues rose from $17 million to $6.7 billion. [8]
In 1979, Stryker became a public company via an initial public offering. [8]
In 2003, Stephen P. MacMillan joined Stryker as president and CEO.
In 2007, Stryker sold its Physiotherapy Associates division to private equity firm Water Street Healthcare Partners for $150 million.
In February 2012, MacMillan resigned and Curt R. Hartman was named Interim Chief Executive Officer and vice president and chief financial officer. William U. Parfet was named non-executive chairman of the board. In October 2012, Kevin A. Lobo was appointed as president and chief executive officer. [9]
In 2023, Stryker introduced a minimally invasive bunion treatment system, Prostep MIS Lapidus, which aims to reduce bunion recurrence, minimize scarring, and lower opioid use. [10]
Year | Company | Description | Ref(s). |
---|---|---|---|
1979 | Osteonics | Entrance to the replacement hip, knee, and other orthopedic implants market. | [5] |
1981 | SynOptics | Entrance to endoscopy business. | [5] |
1998 | Howmedica | Orthopaedic division of Pfizer. Price was $1.9 billion. Howmedica became Stryker Orthopaedics. | [11] [12] [13] |
August 2000 | Guided Technologies | Developer and manufacturer of optical localizers. | [14] |
July 2002 | Spinal Implant Business of Surgical Dynamics | Price was $135 million. | [15] |
August 2004 | SpineCore | Development of artificial spinal disks. Price was $120 million. | [16] |
February 2005 | eTrauma.com | Price was $50 million. Development of software for Picture archiving and communication system (PACS) | [17] |
March 2006 | Sightline Technologies | Manufacturer of gastrointestinal endoscopy apparatuses. Price was $50 million. Partially closed in 2008. | [18] [19] |
January 2006 | PlasmaSol | Technologies allowing sterilization of various MedSurg equipments. Price was $17.5 million. | [20] [21] |
December 2009 | Ascent Healthcare Solutions | Reprocessing and remanufacturing of medical devices in the U.S. Price was $525 million. | [22] |
January 2011 | Neurovascular Division of Boston Scientific | Products used for the minimally invasive treatment of hemorrhagic and ischemic stroke. Price was $1.5 billion. | [23] |
June 2011 | Orthovita | A biomaterials company specializing in bone augmentation and substitution technologies. | [24] |
July 2011 | Memometal Technologies | Manufactures and markets products for extremity indications based on its proprietary methods for preparing and manufacturing a shape memory metal alloy. Price was up to $162 million. | [25] [26] |
August 2011 | Concentric Medical | Price was $135 million. Devices for the removal of thrombus in patients experiencing acute ischemic stroke along with a broad range of AIS access products. | [27] [28] |
November 2012 | Surpass Medical | Flow diversion stent technology to treat brain aneurysms using a mesh design and delivery system. Price was $135 million. | [29] |
March 2013 | Trauson Holdings | Trauma manufacturer in China. Price was $764 million. | [30] |
December 2013 | MAKO Surgical Corp. | Surgical robotic arm assistance platforms, most notably the RIO (Robotic Arm Interactive Orthopedic System) as well as orthopedic implants used by orthopedic surgeons for use in partial knee and total hip arthroplasty. Price was $1.65 billion. | [31] |
March 2014 | Patient Safety Technologies | Safety-Sponge System, an integrated counting and documentation system that prevents surgical sponges and towels from being unintentionally left in patients after surgical procedures. Price was $85 million. | [32] |
March 2014 | Pivot Medical | Products for hip arthroscopy. | [33] |
April 2014 | Berchtold Holding AG | Surgical tables, equipment booms, and surgical lighting systems. Price was $172 million. | [34] |
July 2014 | Small Bone Innovations | Products that help surgeons treat and replace small bones and joints. Price was $358 million. | [35] |
September 2015 | Muka Metal | Manufactures hospital beds and patient furniture in Kayseri. | [36] |
February 2016 | Sage Products | Disposable device maker. Price was $2.78 billion. | [37] |
February 2016 | Physio-Control | Maker of defibrillators. Price was $1.28 billion. | [38] |
June 2017 | Arthrogenx | Cobra reusable suture passer for arthroscopic rotator cuff repair | [39] |
September 2017 | Novadaq | Fluorescence imaging systems. Price was $701 million. | [40] |
October 2017 | Vexim | Minimally invasive treatment of vertebral fractures. Price was €183 million. | [41] |
December 2017 | Entellus Medical | Minimally invasive products for the treatment of various ENT diseases. Price was $662 million. | [42] |
May 2018 | Hygia Health Services | Reprocessing of patient care single-use devices. | [43] |
June 2018 | SafeAir AG | Surgical smoke evacuation. | [44] |
September 2018 | Invuity | Surgical lighting company. Price was $190 million. | [45] [46] |
October 2018 | HyperBranch Medical Technology | Maker of Adherus AutoSpray dural sealant. Price was $220 million. | [47] |
November 2018 | K2M Group Holdings | Spinal surgery device-maker. Price was $1.4 billion. | [48] |
February 2019 | Arrinex | Manufacturer of cryoablation technology for the treatment of chronic rhinitis. | [49] |
March 2019 | OrthoSpace | Rotator cuff implant. Price was up to $220 million. | [50] |
October 2019 | Mobius Imaging and GYS Tech | Intra-operative imaging. Price was $370 million upfront, plus up to $130 million in contingent payments. | [51] |
November 2020 | Wright Medical Group | Upper-body implants. Price was $5.4 billion. | [52] |
January 2021 | OrthoSensor | Sensor technology for use in total joint replacement procedures | [53] |
April 2021 | TMJ Concepts | Patient-specific implants for TMJ reconstruction. | [54] |
September 2021 | Gauss Surgical | Platform for real-time monitoring of blood loss during surgery. | [55] |
January 2022 | Vocera Communications | Digital patient outreach tools. Price was $2.97 billion. | [56] [57] |
March 2024 | SERF SAS | Joint replacements. | [58] |
September 2024 | Care.ai | Artificial intelligence-based tools for hospitals. | [59] |
September 2024 | NICO Corporation | Minimally invasive solutions for brain tumor removal and stroke care. | [60] |
February 2025 | Inari Medical | Catheter-based mechanical thrombectomy systems to treat vascular disease. Price was $4.9 billion. | [61] |
In 2007 and 2008, the company received three FDA warning letters citing issues in compliancy.
The first of these, a seven-page correspondence, named various issues at an Irish manufacturing facility, such as untimely fix of failures and procedural noncompliance in the testing of failed or otherwise problem-prone devices. [63] The second, sent November 2007, cited issues at the firm's Mahwah, New Jersey, facility, including poor fixation of hip implant components, in some instances requiring mitigation by revision surgeries; exceeded microbial level violations in the cleaning and final packaging areas of the sterile implants; and failure to institute measures in prevention of recurrence of these and other problems. [64] The third warning letter, sent April 2008, cited issues at the firm's biotechnology facility in Hopkinton, Massachusetts related to quality and noncompliance including falsification of documents relevant to the selling of products to hospitals which are to be sold under a limited, government-mandated basis. Stryker maintains that employees involved in the falsification of documents have since been terminated. [65]
In August 2010, the company paid $1.35 million to settle claims that it marketed items without regulatory approval and misled health care providers about the use of its products. [66]
Stryker initiated a product recall on several models of medical vacuums sold under the Neptune Waste Management System brand in June and September 2012. The devices, some of which had not been cleared by the Food and Drug Administration, caused a fatal accident when the vacuum was mistakenly used to suction a passive drainage tube. [67] [68]
In 2013, the company agreed to pay $13.2 million to settle charges that it made illicit payments totaling approximately $2.2 million in Argentina, Greece, Mexico, Poland, and Romania. [69] In 2018, the company was fined $7.8 million under the Foreign Corrupt Practices Act for failing to detect the risk of improper payments in sales of products in India, China, and Kuwait. [70]
On 2012, FDA has issued a warning for the Stryker Rejuvenate hip replacement after it was discovered that the hip replacement was considered defective and can cause similar side effects to DePuy Synthes hip implants. As a result, in 2014, Stryker was fined $1 billion and $2.5 billion, respectively, for its defective Rejuvenate and ABG II hip replacements that can cause excruciating pain. [71]
In 2016, subsidiary company Stryker EMEA Supply Chain Services BV challenged the Dutch authorities' interpretation of procurement nomenclature regarding implant screws intended to be inserted in the human body. The matter was referred to the European Court of Justice for a preliminary ruling on the legal position and on the validity of the relevant EU implementing regulation. [72]
Stryker is among companies that continue business-as-usual in Russia during the 2022 Russian invasion of Ukraine despite international sanctions during the Russian invasion of Ukraine. Research from Yale School of Management evaluating companies' reaction to the Russian invasion put Stryker in the "Grade F" category of "Digging In", meaning "Defying Demands for Exit or Reduction of Activities." [73]
Stryker was recognized by Hermann Simon as a role model for other small to medium-sized business in his book Hidden Champions . [74]